作者
Babak Fallahi, Niloufar Khademi, Najme Karamzade-Ziarati, Armaghan Fard-Esfahani, Alireza Emami-Ardekani, Saeed Farzanefar, Mohammad Eftekhari, Davood Beiki
发表日期
2021/2/1
期刊
Clinical Nuclear Medicine
卷号
46
期号
2
页码范围
e68-e74
出版商
LWW
简介
Background
99m Tc–prostate-specific membrane antigen (PSMA) SPECT/CT is less expensive and readily available modality compared with 68 Ga-PSMA PET/CT for imaging prostate cancer (PC). The aim of this study is to compare the value of these 2 modalities in patients confirmed or suspicious to have metastatic prostate cancer.
学术搜索中的文章
B Fallahi, N Khademi, N Karamzade-Ziarati… - Clinical Nuclear Medicine, 2021